Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy

Lung Cancer

Volumn 30, Issue 2, 2000, Pages 127-134

  Quoix, E ^a   Purohit, A ^a   Faller Beau, M ^b   Moreau, L ^a   Oster, J P ^a   Pauli, G ^a  

^a HÔPITAL CIVIL   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Lactate dehydrogenase; Neuron specific enolase; Prognostic factor; Small cell lung cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; LACTATE DEHYDROGENASE; NEURON SPECIFIC ENOLASE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CELL DEATH; DIAGNOSTIC VALUE; DRUG BLOOD LEVEL; FEMALE; HUMAN; LEUKOCYTE COUNT; LIFE EXPECTANCY; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SMALL CELL; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PHOSPHOPYRUVATE HYDRATASE; PLATINUM COMPOUNDS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033728154     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(00)00131-8     Document Type: Article

References (28)

1. Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer
2. Prognostic factors in small cell lung cancer: Multivariate model based on 778 patients treated with chemotherapy with or without irradiation
3. Pretreatment prognostic factors and scoring system in 407 small cell lung cancer patients
4. An overview of prognostic factors in small cell lung cancer
5. Determinants of improved outcome in small-cell lung cancer: An analysis of 2580 patients Southwest Oncology Group Data Base
6. Small-cell carcinoma of the lung: Derivation of a prognostic staging system
7. Long-term survival in small-cell lung cancer: Post treatment characteristics in patients surviving 5 to 18+ years. An analysis of 1714 consecutive patients
8. Pretreatment prognostic factors for survival in small-cell lung cancer: A new prognostic index and validation of three known prognostic indices in 341 patients
9. The prognostic influence of serum neuron-specific enolase in small-cell lung cancer
10. Neurone specific enolase (NSE) in small cell lung cancer: A tumour marker of prognostic significance?
11. Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer
12. Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): A combined multivariable analysis on data from nine centres
13. Extensive small-cell lung cancer. A randomized comparison of 2 chemotherapy programs with early crossover in instances of failure
14. Early alternating chemotherapy and radiotherapy schedule in limited stage small-cell lung cancer
15. Phase II trial of navelbine in small cell lung cancer
16. Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive stage small-cell lung cancer: A multicenter randomized phase III study
17. Serum neuron-specific enolase. A marker for disease extent and response to therapy for small cell lung cancer
18. Inability of serum neuron-specific enolase to predict disease extent in small cell lung cancer
19. Lactic dehydrogenase in human neoplastic tissues
20. Neuron-specific enolase (NSE) in small-cell lung cancer: Longitudinal tumour marker evaluation
21. Prognostic factors in small cell lung cancer: A simple prognostic index is better than conventional staging
22. Prognostic factors in small-cell carcinoma of the lung: An analysis of 1521 patients
23. Can we predict very short term survival in small cell lung cancer
24. The importance of clinical staging in limited small cell lung cancer: A valuable system to separate prognostic subgroups
25. Prognostic significance of supraclavicular lymph nodes in small cell lung cancer. A study from four consecutive clinical trials including 1370 patients
26. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer
27. Utilisation des marqueurs tumoraux dans le cancer bronchique primitif. Recommandations de la societe de Pneumologie de Langue francaise